The politics of insulin

“Cheap generic versions of current first line treatments, metformin and sulfonylureas, are widely available so why does this not apply to insulin?” ask Professors Gale and Yudkin in their insightful commentary in the BMJ.
Edwin A M Gale, John S Yudkin. Politics of affordable insulin. BMJ 2011; 343:d5675

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s